Death panel

It’s a brave new rationing world: Medicare is reportedly poised to refuse to cover Provenge, a new anti-cancer drug, arguing that although the FDA is has found it to be safe and effective, it may not be “reasonable and necessary”.

(Via Althouse.)

Leave a comment